President of Heart Failure Association of the ESC, UK
President of Heart Failure Association of the ESC, UK
Andrew studied at Oxford and Cambridge. He has more than 100,000 citations, and an H-index of 135. He served as Editor-in-Chief of the International Journal of Cardiology from1999 to 2016. Andrew published the first randomised trial of exercise training for CHF. Andrew has been Chairman or Committee member of multiple major clinical trials. He has served Head of Cardiology at Imperial College and Royal Brompton Hospital, London, as Dean of Medicine and Deputy Vice-President at the University of Sydney, and as Academic Vice-President at the University of Warwick, UK, where he continues as Professor of Cardiology. He is presently President of the Heart Failure Association of the ESC. He has founded two successful UK biotech companies (PsiOxus and Actimed) and is a trained board director with extensive experience in all major board roles including company Chair.